Hepatitis E Virus ORF2 Inhibits RIG-I Mediated Interferon Response

Area of Science:

• Immunology
• Virology
• Molecular Biology

Background:

• Innate immunity is crucial for controlling viral infections.
• Hepatitis E virus (HEV) is sensed by the cytosolic pattern recognition receptor RIG-I.
• Understanding HEV's immune evasion mechanisms is vital for therapeutic development.

Purpose of the Study:

• To investigate how HEV interacts with the host innate immune system.
• To identify the specific HEV component responsible for immune modulation.
• To elucidate the molecular mechanism of HEV immune evasion.

Main Methods:

• Reporter assays using interferon-inducible promoters.
• Quantitative reverse transcription polymerase chain reaction (qRT-PCR).
• Enzyme-linked immunosorbent assay (ELISA).
• Immunofluorescence microscopy.
• Analysis of HEV capsid protein (ORF2) variants.

Main Results:

• Full-length HEV ORF2 protein inhibits RIG-I-mediated interferon responses.
• ORF2 modulates both synthetic and virus-induced RIG-I activation.
• ORF2 antagonizes Toll-like receptor (TLR) pathways.
• Inhibition occurs upstream of IRF3 activation, downstream of adapter proteins (IPS-1, MyD88, TRIF).

Conclusions:

• HEV ORF2 protein is a key viral factor that suppresses host antiviral signaling.
• HEV employs ORF2 to evade innate immune detection via RIG-I and TLR pathways.
• This study reveals a novel mechanism of viral immune evasion by HEV.